PerMediCon 2016

The Innovative Congress for personalized medicine

Top-class interdisciplinary discussions in front of an international audience: According to the motto “Redefining Health Care in the Genome Aera”  experts from different countries discuss progress and challenges in personalized medicine. Key topic of the two-day congress exhibition of this year is the Genomic Oncology, from particular interest to patient benefit.

The following topics are, among other things, discussed controversially:

What does Genomic Oncology require?

- evidence-based performance controlling

- specialization and centralization

- cross-sectoral cooperation

- new skills for the medical profession

- “Health Literacy“ in the broader public

The exhibition area with numerous enterprise offers plenty of  space for networking, personal exchange and detailed specialist discussions.

The scientific program is once again enriched by the “Call-for-Projects”. Innovative and practical oriented projects products, technologies and services in the context of personalized medicine are presented.

PerMediCon unites three different meeting formats in one event: Congress, Trade Exhibition and Call for Projects. The superordinate objective was to enable participants from different disciplines and therapeutic areas to learn from each other and to form networks in order to facilitate and accelerate the adoption of personalized medicine into medical practice – for the benefit of the patients’ health.

Key Issue 2016: Genome Oncology

The greatest progress in personalized medicine is the development in oncology. There are already many approved drugs. Hardly a month passes without reports on new, promising drugs. Traditional therapy concepts are on trial. Interdisciplinary approaches are the focus. Therefore clinics and specialist practices need to be adjusted organization to this development by new networks and forms if they want to treat their patients according to the latest research.

As part of the congress - under the scientific leadership of Congress Presidents Prof. Dr. Rita Schmutzler and Prof. Dr. Jürgen Wolf - international experts present latest research findings and innovations in personalized cancer care.

The aim of the congress is to provide the exchange with participating physicians, researchers and clinics to establish the personalized cancer therapy for the future.

In addition, it is also important to position Germany as a location for internationally visible innovation for Health Research.